Anti-Canine Parvovirus monoclonal antibody, clone 5E1

For a CPV system, prediction of focal flux distribution at the receiver area will give insight to more effective, energy efficient designs and to estimate power output. An experimental method for in-situ prediction of heat flux distribution profile using inverse heat transfer technique on a flat plate receiver for a CPV square parabolic dish is presented. An IR camera is used to measure the temperature of the concentrated receiver surface. The receiver domain is discretised into several heat flux elements and heat flux values for each grid is then estimated using the measured infrared (IR) pixel temperature and ordinary least square. A 3-D steady state heat conduction equation with convection and radiation heat loss boundary is regarded as the forward problem. The simulated temperatures generated from the solution of forward problem using the predicted heat flux distribution and measured temperature distribution are in close agreement. For validation purpose, the concentrated heat flux is also measured using Gardon and Schmidt-Boelter heat flux sensor. The peak predicted focal heat flux on the receiver is found to be 37.41 kW/m(2) whereas the heat flux value measured by the flux sensor is 39.15 kW/m(2) within the deviation of 4.4%. (c) 2019 Elsevier Ltd. All rights reserved.

Purpose Five-year kidney graft loss currently stands at about 30%. We evaluate the clinical utility of a blood test measuring donor-derived cell-free DNA that detects rejection earlier and, potentially, improves diagnostic and therapeutic accuracy. Methods In a randomized controlled experiment, we measured the clinical practice of 175 practicing nephrologists, both with and without the use of dd-cfDNA testing. Providers cared for six simulated post-renal transplant patient cases whose ages ranged from 30 to 75 years and were 3-24 months post-transplant with typical presentations. Results 154 nephrologists completed two rounds of simulated cases. At baseline, the study arms performed similarly, demonstrating no significant differences either in primary diagnosis (p = 0.853), decisions to biopsy or refer to transplant center (p = 1.000), or therapeutic management (p = 0.488). After introduction of the dd-cfDNA test, intervention nephrologists were more likely to arrive at the diagnosis of rejection (OR 4.00, 95% CI 1.93-8.30), make a correct decision on biopsy/transplant center referral (OR 11.07, 95% CI 4.87-25.16), and properly adjust therapeutic management (OR 2.37, 95% CI 1.07-5.24). Conclusion A sample of nationally representative, practicing nephrologists given dd-cfDNA to evaluate post-transplant patients were more likely to correctly diagnose early and subclinical allograft rejection, to send for biopsy or refer to transplant center, and to appropriately change treatment than those nephrologists without dd-cfDNA access.